respiratory
COPD

Daily statin shown to cut COPD exacerbations

Simvastatin has shown benefit as an adjunct therapy in COPD, significantly extending the time to first exacerbation as well as the overall rate of exacerbations, finds new research which contradicts previous trials. The double-blind randomised controlled trial conducted in Austria found that simvastatin at a daily dose of 40mg cut yearly COPD exacerbations by 23% ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic